CCL2 and hepatocellular carcinoma: The HCC group of patients did not significantly differ from patients with end-stage ALD without HCC in terms of CCL2 concentration (155.1 [114.2–223.4] pg/mL, p > 0.05) or in any of the remaining 12 cytokines (p > 0.05 for all analyses).